MJ tracks the Prime Alternative Harvest Index, designed to measure the performance of companies within the cannabis ecosystem benefitting from global medicinal and recreational cannabis legalization initiatives. First U.S. and world’s largest ETF to target the global cannabis industry. Many other significant applications for cannabis and THC based medicines and treatments ranging from epilepsy to cancer treatment to non-opioid pain management. The global cannabis market is expected to grow at a CAGR of around 17% and reach $55.8 billion by 2025.¹